Tags

Type your tag names separated by a space and hit enter

Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer.
Cancer Nurs. 2015 Jan-Feb; 38(1):E55-60.CN

Abstract

BACKGROUND

Decision aids (DAs) have been developed in several health disciplines to support decision making informed by evidence, such as the benefits and risks of different treatment options. Decision aids can improve the decision-making process by reducing decisional conflict and helping patients to participate in decision making.

OBJECTIVE

The aim of this study was to design and develop a DA for treatment decision making in localized prostate cancer in Spain with regard to surgery, radiotherapy, or watchful waiting.

INTERVENTIONS/METHODS

We developed a DA based on the principles of the International Patient Decision Aid Standards Collaboration and according to the Ottawa Decision Support Framework. The structural development process involved DA developers, expert feedback, use of the Delphi method, and patient feedback. We conducted a pilot test on 34 men with localized prostate cancer.

RESULTS

The DA is a structured booklet. According to the International Patient Decision Aid Standards checklist, the DA scored 22 of 27 points (81.48%). The development process section scored 22 of 24 points (91.6%), and the effectiveness of the decision-making process section scored 6 of 6 (100%). The clinical pilot test yielded positive feedback regarding the design, images, understandability, usability, explanations, and amount of information in the DA.

CONCLUSIONS

We developed a Spanish DA with a strong quality score to help patients make an informed choice regarding their prostate cancer treatment. Future research will assess the impact of the DA and its association with improved decision making.

IMPLICATIONS FOR PRACTICE

This tool provides information about the risks and benefits of different treatment options and helps patients to understand the importance of their own values for informing treatment choices.

Authors+Show Affiliations

Author Affiliations: School of Health Science-TecnoCampus, Department of Nursing, University Pompeu Fabra, Mataró (Ms Chabrera); Department of Oncology, Catalan Institute of Oncology, Badalona (Ms Chabrera and Dr Font); Department of Radiation Oncology, Oncology Catalan Institute, Badalona (Dr Caro); Department of Urology, Germans Trias i Pujol University Hospital, Badalona (Dr Areal); and Hospital Clinic, Barcelona, Spain (Dr Zabalegui).No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24831045

Citation

Chabrera, Carolina, et al. "Developing a Decision Aid to Support Informed Choices for Newly Diagnosed Patients With Localized Prostate Cancer." Cancer Nursing, vol. 38, no. 1, 2015, pp. E55-60.
Chabrera C, Font A, Caro M, et al. Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer. Cancer Nurs. 2015;38(1):E55-60.
Chabrera, C., Font, A., Caro, M., Areal, J., & Zabalegui, A. (2015). Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer. Cancer Nursing, 38(1), E55-60. https://doi.org/10.1097/NCC.0000000000000140
Chabrera C, et al. Developing a Decision Aid to Support Informed Choices for Newly Diagnosed Patients With Localized Prostate Cancer. Cancer Nurs. 2015 Jan-Feb;38(1):E55-60. PubMed PMID: 24831045.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer. AU - Chabrera,Carolina, AU - Font,Albert, AU - Caro,Mónica, AU - Areal,Joan, AU - Zabalegui,Adelaida, PY - 2014/5/17/entrez PY - 2014/5/17/pubmed PY - 2016/6/9/medline SP - E55 EP - 60 JF - Cancer nursing JO - Cancer Nurs VL - 38 IS - 1 N2 - BACKGROUND: Decision aids (DAs) have been developed in several health disciplines to support decision making informed by evidence, such as the benefits and risks of different treatment options. Decision aids can improve the decision-making process by reducing decisional conflict and helping patients to participate in decision making. OBJECTIVE: The aim of this study was to design and develop a DA for treatment decision making in localized prostate cancer in Spain with regard to surgery, radiotherapy, or watchful waiting. INTERVENTIONS/METHODS: We developed a DA based on the principles of the International Patient Decision Aid Standards Collaboration and according to the Ottawa Decision Support Framework. The structural development process involved DA developers, expert feedback, use of the Delphi method, and patient feedback. We conducted a pilot test on 34 men with localized prostate cancer. RESULTS: The DA is a structured booklet. According to the International Patient Decision Aid Standards checklist, the DA scored 22 of 27 points (81.48%). The development process section scored 22 of 24 points (91.6%), and the effectiveness of the decision-making process section scored 6 of 6 (100%). The clinical pilot test yielded positive feedback regarding the design, images, understandability, usability, explanations, and amount of information in the DA. CONCLUSIONS: We developed a Spanish DA with a strong quality score to help patients make an informed choice regarding their prostate cancer treatment. Future research will assess the impact of the DA and its association with improved decision making. IMPLICATIONS FOR PRACTICE: This tool provides information about the risks and benefits of different treatment options and helps patients to understand the importance of their own values for informing treatment choices. SN - 1538-9804 UR - https://www.unboundmedicine.com/medline/citation/24831045/Developing_a_decision_aid_to_support_informed_choices_for_newly_diagnosed_patients_with_localized_prostate_cancer_ L2 - https://doi.org/10.1097/NCC.0000000000000140 DB - PRIME DP - Unbound Medicine ER -